Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SJC Van Gerwen
PO-484 Development of a Two-Step Screening-And-Confirmation Approach to Efficiently Identify Synergistic Drug Combinations With the Parp Inhibitor Niraparib
Related publications
Development of PARP and Immune-Checkpoint Inhibitor Combinations
Cancer Research
Cancer Research
Oncology
A Computational Approach for Identifying Synergistic Drug Combinations
PLoS Computational Biology
Molecular Neuroscience
Evolution
Ecology
Genetics
Behavior
Molecular Biology
Systematics
Simulation
Cellular
Computational Theory
Mathematics
Modeling
Network Target for Screening Synergistic Drug Combinations With Application to Traditional Chinese Medicine
BMC Systems Biology
Molecular Biology
Applied Mathematics
Structural Biology
Simulation
Computer Science Applications
Modeling
Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors With Three Different Drug Combinations
PLoS ONE
Multidisciplinary
In Vivo Anti-Tumor Activity of the PARP Inhibitor Niraparib in Homologous Recombination Deficient and Proficient Ovarian Carcinoma
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Developing Synergistic Drug Combinations to Restore Antibiotic Sensitivity in Drug-Resistant Mycobacterium Tuberculosis
Nanomedicine of Synergistic Drug Combinations for Cancer Therapy – Strategies and Perspectives
Journal of Controlled Release
Pharmaceutical Science
Screening Strategies to Identify New Chemical Diversity for Drug Development to Treat Kinetoplastid Infections – CORRIGENDUM
Parasitology
Animal Science
Zoology
Parasitology
Infectious Diseases
Barrier to Resistance of Dolutegravir in Two-Drug Combinations
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
